by Eric Christianson | Nov 10, 2019 | Drug Interaction Case Studies and Education For Pharmacists, Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Metformin is the go-to first-line medication in type 2 diabetes. While drug interactions aren’t incredibly common with its use, we should be aware of OCT inhibition and the potential effects that this might cause. Under normal circumstances, this isn’t...
by Eric Christianson | Nov 6, 2019 | Drug Interaction Case Studies and Education For Pharmacists
In the case scenario below, I discuss the implications of the verapamil phenytoin interaction. JS is a 38-year-old male who has been on phenytoin for seizure prophylaxis for several years. He reports to his primary care provider complaining of severe headaches. He is...
by Eric Christianson | Nov 3, 2019 | Educational Case Studies For Pharmacists
KS is a 79-year-old female. She states that she takes too many pills and would like to try to reduce some. Here’s her list. Aspirin 81 mg dailyClopidogrel 75 mg dailyPantoprazole 40 mg dailyValsartan 80 mg dailyMetoprolol 25 mg BIDAmlodipine 5 mg...
by Eric Christianson | Oct 30, 2019 | Drug Interaction Case Studies and Education For Pharmacists
In this case scenario below, I discuss the mirabegron tamoxifen interaction and how it can impact patient safety. KS is a 61-year-old female who presents with worsening urinary frequency. She has been diagnosed with overactive bladder and place on oxybutynin. She was...
by Eric Christianson | Oct 23, 2019 | Drug Interaction Case Studies and Education For Pharmacists
When the NOACs (sometimes referred to as DOACs) first came out they were heavily promoted as having fewer drug interactions compared to warfarin. This is true, but please remember that “fewer drug interactions” doesn’t mean “no drug...
